Shinva Medical InstrumentLtd Management

Management Kriterienprüfungen 3/4

Shinva Medical InstrumentLtd's CEO ist Baoxian Gong, ernannt in Feb 2022, hat eine Amtszeit von 2.25 Jahren. besitzt direkt 0.009% der Aktien des Unternehmens, im Wert von CN¥891.08K. Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 2.5 Jahre bzw. 3.3 Jahre.

Wichtige Informationen

Baoxian Gong

Geschäftsführender

CN¥2.3m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	2.6yrs
Eigentum des Geschäftsführers	0.01%
Durchschnittliche Amtszeit des Managements	2.8yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	3.7yrs

Jüngste Management Updates

Recent updates

Returns At Shinva Medical InstrumentLtd (SHSE:600587) Are On The Way Up

Sep 16

Is Shinva Medical InstrumentLtd (SHSE:600587) Using Too Much Debt?

Aug 08

Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Business And Shares Still Trailing The Market

Jul 18

Does This Valuation Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Imply Investors Are Overpaying?

Jun 07

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Apr 22

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Mar 28

Geschäftsführer

Baoxian Gong (48 yo)

2.6yrs

Amtszeit

CN¥2,312,900

Vergütung

Mr. Baoxian Gong is General Manager of Shinva Medical Instrument Co., Ltd., since February 23, 2022.

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Baoxian Gong	General Manager	2.6yrs	CN¥2.31m	0.011% CN¥ 1.2m
Juanjuan Zhou	CFO & Director	3.1yrs	CN¥942.70k	0.026% CN¥ 2.8m
Cai Xiang Li	Deputy GM & Secretary of the Board	7.2yrs	CN¥978.80k	0.046% CN¥ 4.9m
Jing Qu	Deputy General Manager	4.4yrs	CN¥1.57m	0.028% CN¥ 3.0m
Jiaqiang Wang	Deputy General Manager	2.1yrs	CN¥1.23m	0.013% CN¥ 1.3m
Qingguo Zhu	Deputy General Manager	2.1yrs	CN¥1.64m	0.014% CN¥ 1.5m

2.8yrs

Durchschnittliche Betriebszugehörigkeit

47yo

Durchschnittliches Alter

Erfahrenes Management: 600587Das Führungsteam des Unternehmens gilt als erfahren (2.5 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Juanjuan Zhou	CFO & Director	3.1yrs	CN¥942.70k	0.026% CN¥ 2.8m
Ailing Pan	Independent Director	4.2yrs	CN¥80.00k	keine Daten
Yu Quan Wang	Chairman	4.3yrs	CN¥1.25m	0.046% CN¥ 4.9m
Weijun Gu	Independent Director	4.3yrs	CN¥80.00k	0.0014% CN¥ 147.8k
Hongtao Cui	Employee Representative Director	7.4yrs	CN¥2.60m	0.030% CN¥ 3.2m
Xiao Li Zhao	Director	7.4yrs	CN¥1.03m	keine Daten
Yueyong Wang	Director	3.7yrs	CN¥33.30k	keine Daten
Xiao Li Li	Director	3.7yrs	CN¥94.00k	keine Daten
Li Yong Jiang	Independent Director	3.7yrs	CN¥80.00k	keine Daten
Lehai Mou	Chairman of the Supervisory Board	3.7yrs	keine Daten	keine Daten
Yuan Li	Independent Director	3.1yrs	CN¥80.00k	keine Daten
Fuquan Zhang	Director	1.2yrs	CN¥33.30k	keine Daten

3.7yrs

Durchschnittliche Betriebszugehörigkeit

56.5yo

Durchschnittliches Alter

Erfahrener Vorstand: 600587Die Vorstandsmitglieder gelten als erfahren (3.3 Jahre durchschnittliche Amtszeit).

Shinva Medical InstrumentLtd Management

Management Kriterienprüfungen 3/4

Wichtige Informationen

Jüngste Management Updates

Shinva Medical Instrument Co.,Ltd., Annual General Meeting, Apr 18, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Returns At Shinva Medical InstrumentLtd (SHSE:600587) Are On The Way Up

Second quarter 2024 earnings released: EPS: CN¥0.74 (vs CN¥0.43 in 2Q 2023)

Is Shinva Medical InstrumentLtd (SHSE:600587) Using Too Much Debt?

Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Business And Shares Still Trailing The Market

Now 19% overvalued

Shinva Medical Instrument Co.,Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Now 22% overvalued

Does This Valuation Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Imply Investors Are Overpaying?

Investor sentiment deteriorates as stock falls 17%

Dividend increased to CN¥0.50

First quarter 2024 earnings released: EPS: CN¥0.45 (vs CN¥0.46 in 1Q 2023)

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Full year 2023 earnings: EPS and revenues miss analyst expectations

Shinva Medical Instrument Co.,Ltd., Annual General Meeting, Apr 18, 2024

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Investor sentiment deteriorates as stock falls 19%

Shinva Medical Instrument Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.24 in 3Q 2022)

Shinva Medical Instrument Co.,Ltd. to Report Q3, 2023 Results on Oct 25, 2023

Second quarter 2023 earnings released: EPS: CN¥0.57 (vs CN¥0.48 in 2Q 2022)

New minor risk - Dividend sustainability

Full year 2022 earnings released: EPS: CN¥1.23 (vs CN¥1.37 in FY 2021)

Investor sentiment improves as stock rises 17%

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.24 (vs CN¥0.27 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.48 (vs CN¥0.45 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to CN¥41.65

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.20 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.45 (vs CN¥0.25 in 2Q 2020)

Investor sentiment improved over the past week

Zou Huiling acquired 16.67% stake in Beijing Huaco Healthcare Technologies Co., Ltd. from Shinva Medical Instrument Co., Ltd. (SHSE:600587) for CNY 25 million.

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.36 (vs CN¥0.08 in 1Q 2020)

New 90-day low: CN¥12.23

New 90-day low: CN¥13.25

New 90-day low: CN¥14.41

New 90-day low: CN¥14.78

New 90-day low: CN¥15.88

Third quarter earnings released

Shinva Medical Instrument Co., Ltd. to Report Q3, 2020 Results on Oct 31, 2020

First half earnings released

Nanyang Great Health Medical Care Industry Development Co., Ltd acquired 80% stake in Nanyang Orthopedics High-tech Zone Hospital Co., Ltd. from Shinva Medical Instrument Co., Ltd. (SHSE:600587) for CNY 53.8 million.

New 90-day high - CN¥18.41

Shinva Medical Instrument Co., Ltd. to Report First Half, 2020 Results on Aug 29, 2020

Geschäftsführer

Amtszeit

Vergütung

Führungsteam

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter